Duke Cancer Center

Duke University Medical Center

Durham, NC

Sorting 3 by

Accepting patients

PTSD Mobile App

PTSD Mobile App for Cancer Survivors
Learn more
  • Observational Trial
  • Transplant Service
  • 20-506

Accepting patients

MMSET Inhibitor

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Learn more
  • Phase 1
  • Myeloma Service
  • 23-222

Accepting patients

CaMMouflage

A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage Trial)
Learn more
  • CAR T Cell (Allogeneic)
  • BCMA
  • Phase 1
  • Myeloma Service
  • 23-182